Free Trial
CVE:VPT

VentriPoint Diagnostics (VPT) Stock Price, News & Analysis

VentriPoint Diagnostics logo
C$0.13 -0.01 (-3.70%)
As of 08/7/2025 02:13 PM Eastern

About VentriPoint Diagnostics Stock (CVE:VPT)

Key Stats

Today's Range
C$0.13
C$0.13
50-Day Range
C$0.10
C$0.17
52-Week Range
C$0.08
C$0.21
Volume
500 shs
Average Volume
188,978 shs
Market Capitalization
C$21.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VentriPoint Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

VPT Stock News Headlines

Ventripoint Diagnostics Ltd. (VPT.V) - Yahoo Finance
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.
See More Headlines

VPT Stock Analysis - Frequently Asked Questions

VentriPoint Diagnostics' stock was trading at C$0.10 at the beginning of the year. Since then, VPT stock has increased by 30.0% and is now trading at C$0.13.

Shares of VPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that VentriPoint Diagnostics investors own include Resverlogix (RVX), Meta Platforms (META), Sphere 3D (ANY), Aptose Biosciences (APTO), Antibe Therapeutics (ATE), AuRico Gold Inc. Ordinary Share (AUQ) and Baytex Energy (BTE).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
CVE:VPT
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$5.25 million
Net Margins
-3,732.10%
Pretax Margin
N/A
Return on Equity
388.60%
Return on Assets
-136.72%

Debt

Debt-to-Equity Ratio
-58.56
Current Ratio
0.28
Quick Ratio
6.67

Sales & Book Value

Annual Sales
C$140.67 thousand
Price / Sales
149.90
Cash Flow
C$0.02 per share
Price / Cash Flow
5.53
Book Value
C($0.02) per share
Price / Book
-8.32

Miscellaneous

Outstanding Shares
162,204,000
Free Float
N/A
Market Cap
C$21.09 million
Optionable
Not Optionable
Beta
0.39
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (CVE:VPT) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners